• Mission & Governance
• Services Overview
• How to Get Involved
• Standing Committees
• NCSL Foundation

• Issue Areas: A-Z
• State-Federal Relations
• NCSL Standing Committees
• News from D.C. and the States

• About State Legislatures
• Elections, Campaigns & Redistricting
• NCSL's StateConnect Directory
• Web Sites

• Online Guide to NCSL Services
• Staff Sections and Networks
• Meetings & Professional Development
• Staff Directories

• Meetings Calendar
• Online Registration
• Meetings Home Page
• Legislative Summit

• Bookstore
• State Legislatures Magazine
• NCSL's StateConnect Directory

Benedetto Vitiello, M.D.
Chief, Child and Adolescent Treatment and Preventive Interventions Research Branch
National Institute of Mental Health,  Room 7147
6001 Executive Blvd., MSC 9633
Bethesda, MD 20892-9633
Tel. 301/443-4283
Fax. 301/443-4045
bvitiell@mail.nih.gov

Biographical Sketch:

Dr. Vitiello is a psychiatrist with expertise in psychopharmacology and treatment research.  He has been with National Institute of Mental Health since 1989.  He has been involved in clinical trials in various areas, including child, adolescent, adult, and geriatric psychiatry, and in patients with HIV infection.  He currently participates in a number of ongoing multisite trials, such as the Treatment for Adolescents with Depression Study (TADS), the Research Units on Pediatric Psychopharmacology (RUPP) network studies, and multisite trials in schizophrenia, treatment resistant depression, and preschool attention deficit hyperactivity disorder.  Dr. Vitiello has authored or co-authored about 150 scientific publications, of which about 100 in peer-reviewed journals.

A Selection of Recent Publications:

Vitiello B, Aman MG, Scahill L, McCracken JT, McDougle CJ, Tierney E, Davies M, Arnold LE: Research knowledge among parents of children participating in a randomized clinical trial.   J Am Acad Child Adolesc Psychiatry 2005;44:145-149.

The TADS Team: The Treatment for Adolescents with Depression Study (TADS): Short-Term Effectiveness and Safety Outcomes.  JAMA 2004;292:807-820.

Vitiello B, Swedo S: Antidepressant medications in children and adolescents.  N Engl Med J 2004;350:1489-1491.

Vitiello B: Ethical Considerations in Psychopharmacological Research Involving Children and Adolescents.  Psychopharmacol 2003;171:86-91

Vitiello B, Riddle MA, Greenhill LL, March JS, Levine J, Schachar R, Abikoff H, Zito J, McCracken J, Walkup J, Findling RL, Robinson J, Cooper T, Davies M, Varipatis E,  Labellarte M, Scahill L, Capasso L: How Can We Improve the Assessment of Safety in Child and Adolescent Psychopharmacology?  J Am Acad Child Adolesc Psychiatry 2003; 42:634-641

RUPP Anxiety Study Group: Searching for Moderators and Mediators of Pharmacological Treatment Effects in Children and Adolescents with Anxiety Disorders. J Am Acad Child Adolesc Psychiatry 2003; 42:13-21

Vitiello B, Burnam A, Bing EG, Beckman R, Shapiro MF: Use of Psychotropic Medications Among HIV-Infected Patients in the United States.  Am J Psychiatry 2003;160:547-554

 Webcast Main Page